Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

29

Revenue 2017

Soliris

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.

The year of the blockbuster

The year of the blockbuster

These include Juno Therapeutics’CAR T-cell therapy, lisocabtagene maraleucel, for diffuse large B-cell lymphoma, and Alexion’s next-generation Soliris treatment, ravulizumab, for paroxysmal nocturnal haemoglobinuria.

Alexion uses priority review voucher for Soliris follow-up

Alexion uses priority review voucher for Soliris follow-up Alexion uses priority review voucher for Soliris follow-up. Files ravulizumab for paroxysmal nocturnal haemoglobinuria. ... Alexion is pulling out all the stops to get speedy approval for a follow-up to its rare blood disorder therapy Soliris, using a

Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more

Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more gMG). It also unveiled positive top-line data from its Phase III trial of ALXN1210, a long-acting form of its flagship treatment Soliris. ... ALXN1210 in patients with paroxysmal nocturnal hemoglobinuria (PNH) need only be administered once every eight

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion adds to pipeline rebuild with $855m Wilson buy Alexion Pharma’s drive to reduce its reliance on cash cow Soliris has gone up a gear with a $855m offer for rare disease company Wilson Therapeutics. ... has a long way to go before it bears comparison with Soliris’$3.1bn turnover.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics